Evidence
Nutrients. 2023 Jul 24;15(14):3265. doi: 10.3390/nu15143265.
ABSTRACT
Autism Spectrum Disorder (ASD) is characterized by varying degrees of difficulty in social interaction and communication. These deficits are often associated with gastrointestinal symptoms, indicating alterations in both intestinal microbiota composition and metabolic activities. The intestinal microbiota influences the function and development of the nervous system. In individuals with ASD, there is an increase in bacterial genera such as Clostridium, as well as species involved in the synthesis of branched-chain amino acids (BCAA) like Prevotella copri. Conversely, decreased amounts of Akkermansia muciniphila and Bifidobacterium spp. are observed. Epigallocatechin-3-gallate (EGCG) is one of the polyphenols with the greatest beneficial activity on microbial growth, and its consumption is associated with reduced psychological distress. Therefore, the objective of this review is to analyze how EGCG and its metabolites can improve the microbial dysbiosis present in ASD and its impact on the pathology. The analysis reveals that EGCG inhibits the growth of pathogenic bacteria like Clostridium perfringens and Clostridium difficile. Moreover, it increases the abundance of Bifidobacterium spp. and Akkermansia spp. As a result, EGCG demonstrates efficacy in increasing the production of metabolites involved in maintaining epithelial integrity and improving brain function. This identifies EGCG as highly promising for complementary treatment in ASD.
PMID:37513683 | DOI:10.3390/nu15143265
Add to Google Keep
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D
Real-Time Evidence Search [Psychiatry]
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
🌐 90 Days
VR Related Evidence Matrix
- Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
- Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder
- Functional contribution of the intestinal microbiome in autism spectrum disorder, attention deficit hyperactivity disorder, and Rett syndrome: a systematic review of pediatric and adult studies
- Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota
- Colitis reduces active social engagement in mice and is ameliorated by supplementation with human microbiota members
- Immunoregulatory role of the gut microbiota in inflammatory depression
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder
- Recent alcohol intake impacts microbiota in adult burn patients
- Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- Symbiotic combination of Akkermansia muciniphila and inosine alleviates alcohol-induced liver injury by modulating gut dysbiosis and immune responses
- Systematic Review: Autism Spectrum Disorder and the Gut Microbiota
- Development of non-alcoholic steatohepatitis is associated with gut microbiota but not with oxysterol enzymes CH25H, EBI2, or CYP7B1 in mice
- The Impact of Probiotic Bifidobacterium on Liver Diseases and the Microbiota
- Gut Microbiota in Patients with Non-Alcoholic Fatty Liver Disease without Type 2 Diabetes: Stratified by Body Mass Index
- Effect of a multi-strain probiotic mixture consumption on anxiety and depression symptoms induced in adult mice by postnatal maternal separation
- Effect of a multi-strain probiotic mixture consumption on anxiety and depression symptoms induced in adult mice by postnatal maternal separation
- Nanoparticles alleviate non-alcoholic steatohepatitis via ER stress sensor-mediated intestinal barrier damage and gut dysbiosis
- Lactiplantibacillus plantarum ZDY2013 Inhibits the Development of Non-Alcoholic Fatty Liver Disease by Regulating the Intestinal Microbiota and Modulating the PI3K/Akt Pathway
- Gastrointestinal Microbiota & Symptoms of Depression and Anxiety in Anorexia Nervosa-A Re-Analysis of the MICROBIAN Longitudinal Study
- Punicic acid ameliorates obesity-related hyperlipidemia and fatty liver in mice via regulation of intestinal flora and lipopolysaccharide-related signaling pathways
- People with Autism Spectrum Disorder Could Interact More Easily with a Robot than with a Human: Reasons and Limits
- Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis
- Biomarkers of mitochondrial dysfunction in autism spectrum disorder: A systematic review and meta-analysis
- Innate Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder (ASD)
- How Do Children and Adolescents with ASD Look at Animals? A Scoping Review
- COMPARISON OF GUT MICROBIOTA IN ALCOHOLIC AND METABOLIC-DYSFUNCION ASSOCIATED STEATOTIC LIVER DISEASE IN ANIMAL MODELS
- Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?
- From gut to liver: unveiling the differences of intestinal microbiota in NAFL and NASH patients
- Bacillus coagulans regulates gut microbiota and ameliorates the alcoholic-associated liver disease in mice
- Understanding the role of ursodeoxycholic acid and gut microbiome in non-alcoholic fatty liver disease: current evidence and perspectives
- Molecular profiling of the hippocampus of children with autism spectrum disorder
- Akkermansia muciniphila: a potential candidate for ameliorating metabolic diseases
- Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients
- Increased gene dosage of RFWD2 causes autistic-like behaviors and aberrant synaptic formation and function in mice
- Aflatoxin B(1) Exposure Exacerbates Chemokine Receptor Expression in the BTBR T(+) Itpr3(tf)/J Mouse Model, Unveiling Insights into Autism Spectrum Disorder: A Focus on Brain and Spleen
- Aflatoxin B(1) Exposure Exacerbates Chemokine Receptor Expression in the BTBR T(+) Itpr3(tf)/J Mouse Model, Unveiling Insights into Autism Spectrum Disorder: A Focus on Brain and Spleen
- Sex differences in autism-like behavior and dopaminergic neurons in substantia nigra of juvenile mice prenatally exposed to valproate
- Colon impairments and inflammation driven by an altered gut microbiota leads to social behavior deficits rescued by hyaluronic acid and celecoxib
- Alzheimer's disease-related presenilins are key to intestinal epithelial cell function and gut immune homoeostasis
- Characterization of Initial Gastrointestinal Evaluation of Children with Autism Spectrum Disorder: A Descriptive Study
- Effect of Osteopathic Manipulation in an Autism Spectrum Child With Speech Impairment and Attention Deficit: A Case Report
- Age at autism spectrum disorder diagnosis and its association with child and family characteristics in a tertiary care hospital in Malaysia
- Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLD
- Applications of PET and SPECT in Patients with Autism Spectrum Disorder
- Towards understanding sex differences in autism spectrum disorders
- A study on the treatment effects of Crataegus pinnatifida polysaccharide on non-alcoholic fatty liver in mice by modulating gut microbiota
- A new intestinal supplement 'Synbiotics' therapeutically regulates gut microbiota and activates PPARs pathway to inhibit Alzheimer's disease progression in mouse models
- The regulation of enteric neuron connectivity by semaphorin 5A is affected by the autism-associated S956G missense mutation
- Tangshen formula targets the gut microbiota to treat non-alcoholic fatty liver disease in HFD mice: A 16S rRNA and non-targeted metabolomics analyses
- Micronutrient Research in Autism Spectrum Disorder. A Clinical Study
- The Application of Extended Reality in Treating Children with Autism Spectrum Disorder
- Probiotics in autism spectrum disorders: a systematic review of clinical studies and future directions
- Roles of Nutrients in the Brain Development, Cognitive Function, and Mood of Dogs and Cats
- Beyond imagination: Sorting out and treating psychosis in the context of autism spectrum disorder
- Parent-child interaction related to brain functional alterations and development outcomes in autism spectrum disorder: A study based on resting state-fMRI
- A comparative study on dietary diversity and gut microbial diversity in children with autism spectrum disorder, attention-deficit hyperactivity disorder, their neurotypical siblings, and non-related neurotypical volunteers: a cross-sectional study
- Gut bacteria-driven homovanillic acid alleviates depression by modulating synaptic integrity
- Occupational therapy interventions in promoting social communication skills among children with autism spectrum disorder: A scoping review
- Oral-Gut-Estrobolome Axis May Exert a Selective Impact on Oral Cancer
- Polysaccharides from Eucommia ulmoides Oliv. Leaves Alleviate Acute Alcoholic Liver Injury by Modulating the Microbiota-Gut-Liver Axis in Mice
- The Interaction between Stress and Inflammatory Bowel Disease in Pediatric and Adult Patients
- Assisted Robots in Therapies for Children with Autism in Early Childhood
Evidence Blueprint
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
Save Evidence Blueprint
Save as PDF
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review
🌐 365 Days
VR Related Evidence Matrix
- Microbiome-Gut-Mucosal-Immune-Brain Axis and Autism Spectrum Disorder (ASD): A Novel Proposal of the Role of the Gut Microbiome in ASD Aetiology
- Between Dysbiosis, Maternal Immune Activation and Autism: Is There a Common Pathway?
- The Role of Short-Chain Fatty Acids and Altered Microbiota Composition in Autism Spectrum Disorder: A Comprehensive Literature Review
- Microbiota in Autism Spectrum Disorder: A Systematic Review
- Impact of pesticides exposure during neurodevelopmental period on autism spectrum disorders - A focus on gut microbiota
- Epigallocatechin-3-gallate ameliorates polystyrene microplastics-induced anxiety-like behavior in mice by modulating gut microbe homeostasis
- Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates
- Epigallocatechin-3-Gallate and Genistein for Decreasing Gut Dysbiosis, Inhibiting Inflammasomes, and Aiding Autophagy in Alzheimer's Disease
- Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder
- Fecal microbiota transplantation in a child with severe ASD comorbidities of gastrointestinal dysfunctions-a case report
- Age and severity-dependent gut microbiota alterations in Tunisian children with autism spectrum disorder
- Multi-omics analyses demonstrate the modulating role of gut microbiota on the associations of unbalanced dietary intake with gastrointestinal symptoms in children with autism spectrum disorder
- Functional contribution of the intestinal microbiome in autism spectrum disorder, attention deficit hyperactivity disorder, and Rett syndrome: a systematic review of pediatric and adult studies
- Host fecal DNA specific methylation signatures mark gut dysbiosis and inflammation in children affected by autism spectrum disorder
- Altered gut microbiota as potential biomarker biomarkers for autism spectrum disorder in early childhood
- Bacteroides fragilis aggravates high-fat diet-induced non-alcoholic fatty liver disease by regulating lipid metabolism and remodeling gut microbiota
- Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients
- Insight into the binding characteristics of epigallocatechin-3-O-gallate and alcohol dehydrogenase: Based on the spectroscopic and molecular docking analysis
- Polystyrene micro- and nanoparticles exposure induced anxiety-like behaviors, gut microbiota dysbiosis and metabolism disorder in adult mice
- Protocol for the safety and efficacy of fecal microbiota transplantation liquid in children with autism spectrum disorder: a randomized controlled study
- Multistrain Probiotics with Fructooligosaccharides Improve Middle Cerebral Artery Occlusion-Driven Neurological Deficits by Revamping Microbiota-Gut-Brain Axis
- Colitis reduces active social engagement in mice and is ameliorated by supplementation with human microbiota members
- Immunoregulatory role of the gut microbiota in inflammatory depression
- The microbiota-gut-brain axis in Huntington's disease: pathogenic mechanisms and therapeutic targets
- Gut microbiota dysbiosis contributes to α-synuclein-related pathology associated with C/EBPβ/AEP signaling activation in a mouse model of Parkinson's disease
- The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
- Precision synbiotics increase gut microbiome diversity and improve gastrointestinal symptoms in a pilot open-label study for autism spectrum disorder
- Serum trimethylamine N-oxide and lipopolysaccharide binding protein levels among children diagnosed with autism spectrum disorder
- Recent alcohol intake impacts microbiota in adult burn patients
- An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders
- Design Path for a Social Robot for Emotional Communication for Children with Autism Spectrum Disorder (ASD)
- Associations of gut microbiota alterations with clinical, metabolic, and immune-inflammatory characteristics of chronic schizophrenia
- Visual Autism
- Microbiome Relationship of gut microbiota and immunological response in obesity-related non-alcoholic fatty liver disease in children
- Akkermansia muciniphila and Alcohol-Related Liver Diseases. A Systematic Review
- Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice
- Pasteurized akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice
- The gut microbiota-brain axis in neurological disorder
- Antibiotics attenuate diet-induced non-alcoholic fatty liver disease without altering intestinal barrier dysfunction
- Boundaries and integration between microbiota, the nervous system, and immunity
- Cyanidin-3-O-Glucoside Alleviates Alcoholic Liver Injury via Modulating Gut Microbiota and Metabolites in Mice
- Dysbiotic Gut Microbiota-Derived Metabolites and Their Role in Non-Communicable Diseases
- Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions
- Altered oral microbiota and immune dysfunction in Chinese elderly patients with schizophrenia: a cross-sectional study
- Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations
- Chronic intestinal pseudo-obstruction: associations with gut microbiota and genes expression of intestinal serotonergic pathway
- Metagenomics revealed a correlation of gut phageome with autism spectrum disorder
- The many faces of microbiota-gut-brain axis in autism spectrum disorder
- Physical exercise plays a role in rebalancing the bile acids of enterohepatic axis in non-alcoholic fatty liver disease
- Symbiotic combination of Akkermansia muciniphila and inosine alleviates alcohol-induced liver injury by modulating gut dysbiosis and immune responses
- Children autism spectrum disorder and gut microbiota: A bibliometric and visual analysis from 2000 to 2023
- Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review
- Systematic Review: Autism Spectrum Disorder and the Gut Microbiota
- Correction of gut dysbiosis as a promising direction in the prevention of neuroinflammation and cognitive impairment
- The enteric nervous system deficits in autism spectrum disorder
- The correlation between gut microbiota and both neurotransmitters and mental disorders: A narrative review
- A High-Fat Diet Increases the Characteristics of Gut Microbial Composition and the Intestinal Damage Associated with Non-Alcoholic Fatty Liver Disease
- Chronic acetyl-L-carnitine treatment alleviates behavioral deficits and neuroinflammation through enhancing microbiota derived-SCFA in valproate model of autism
- Alterations in fecal virome and bacteriome virome interplay in children with autism spectrum disorder
- Fresh Washed Microbiota Transplantation Alters Gut Microbiota Metabolites to Ameliorate Sleeping Disorder Symptom of Autistic Children
- In Vitro Screening for Probiotic Properties of Lactobacillus and Bifidobacterium Strains in Assays Relevant for Non-Alcoholic Fatty Liver Disease Prevention
- Amelioration of the brain structural connectivity is accompanied with changes of gut microbiota in a tuberous sclerosis complex mouse model
- Exploring a novel therapeutic strategy: the interplay between gut microbiota and high-fat diet in the pathogenesis of metabolic disorders
- Familiarization with Mixed Reality for Individuals with Autism Spectrum Disorder: An Eye Tracking Study